Therapies that modulate pathways of interaction between the human microbiome and the host immune system
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
20
NCT04465032
The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD)
Phase: Phase 4
Role: Collaborator
Start: Dec 10, 2019
Completion: Dec 31, 2021
Loading map...